AOA Dx’s First Peer Reviewed Study Accepted for Publication in Prestigious Journal Frontiers in Oncology
AOA Dx, a biotech company developing a new frontier in early-stage cancer detection through its work in glycolipids, is proud to announce the company’s first published peer reviewed clinical study.